AOTI Valuation Multiples

Discover revenue and EBITDA valuation multiples for AOTI and similar public comparables like Pro-Dex, Onward Medical, Edap TMS, Ilex Medical and more.

AOTI Overview

About AOTI

AOTI Inc produces, rents, and sells medical devices to help resolve severe acute and chronic wounds for customers globally. The company provides efficacious topical wound oxygen solutions for use in both the institutional and the home care setting to improve the health, well-being, and independence of patients. Its products include TWO2 Extremity Chamber, TWO2 Multi-Patch.


Founded

2008

HQ

United States

Employees

N/A

Website

aotinc.net

Financials (LTM)

Revenue: $71M
EBITDA: $7M

EV

$202M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

AOTI Financials

AOTI reported last 12-month revenue of $71M and EBITDA of $7M.

In the same LTM period, AOTI generated $62M in gross profit, $7M in EBITDA, and $2M in net income.

Revenue (LTM)


AOTI P&L

In the most recent fiscal year, AOTI reported revenue of $67M and EBITDA of $8M.

AOTI is profitable as of last fiscal year, with gross margin of 87%, EBITDA margin of 11%, and net margin of 4%.

See analyst estimates for AOTI
LTMLast FY202320242025202620272028
Revenue$71M$67M$44M$58M$67M
Gross Profit$62M$58M$38M$51M$58M
Gross Margin87%87%86%88%87%
EBITDA$7M$8M($4M)$3M$8M
EBITDA Margin10%11%(10%)5%11%
EBIT Margin7%8%(13%)2%8%
Net Profit$2M$3M($8M)($2M)$3M
Net Margin3%4%(19%)(3%)4%
Net Debt-$7M---

Financial data powered by Morningstar, Inc.

AOTI Stock Performance

AOTI has current market cap of $194M, and enterprise value of $202M.

Market Cap Evolution


AOTI's stock price is $1.83.

AOTI share price decreased by 0.1% in the last 30 days, and increased by 220.2% in the last year.

AOTI has an EPS (earnings per share) of $0.03.

See more trading valuation data for AOTI
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$202M$194M-0.1%-0.1%124.5%220.2%$0.03

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

AOTI Valuation Multiples

AOTI trades at 2.9x EV/Revenue multiple, and 28.7x EV/EBITDA.

See NTM and 2027E valuation multiples for AOTI

EV / Revenue (LTM)


AOTI Financial Valuation Multiples

As of September 2, 2026, AOTI has market cap of $194M and EV of $202M.

AOTI has a P/E ratio of 97.8x.

LTMLast FY202320242025202620272028
EV/Revenue2.9x3.0x4.6x3.5x3.0x
EV/EBITDA28.7x26.8x(47.1x)76.5x26.8x
EV/EBIT40.3x36.5x(36.5x)160.8x36.5x
EV/Gross Profit3.3x3.5x5.4x3.9x3.5x
P/E97.8x72.8x(23.7x)(110.5x)72.8x
EV/FCFn/m(30.6x)(73.1x)(25.7x)(30.6x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified AOTI Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

AOTI Margins & Growth Rates

AOTI grew revenue by 9% but EBITDA decreased by 10% in the last fiscal year.

In the most recent fiscal year, AOTI reported gross margin of 87%, EBITDA margin of 11%, and net margin of 4%.

See estimated margins and future growth rates for AOTI

AOTI Margins

Last FY202420252026202720282029
Gross Margin87%88%87%87%
EBITDA Margin11%5%11%9%
EBIT Margin8%2%8%7%
Net Margin4%(3%)4%2%
FCF Margin(10%)(13%)(10%)3%

AOTI Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth9%33%14%9%
Gross Profit Growth9%37%13%9%
EBITDA Growth(10%)(162%)186%(10%)
EBIT Growth(14%)(123%)340%(14%)
Net Profit Growth(38%)(79%)(252%)(38%)
FCF Growth(136%)184%(16%)(136%)

Data powered by FactSet, Inc. and Morningstar, Inc.

AOTI Operational KPIs

AOTI's Rule of 40 is 19% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

AOTI's Rule of X is 33% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for AOTI
LTMLast FY202320242025202620272028
Rule of 4025%19%---
Bessemer Rule of X47%33%---
Opex to Revenue-79%98%86%79%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

AOTI Competitors

AOTI competitors include Pro-Dex, Onward Medical, Edap TMS, Ilex Medical, Lucid Diagnostics, Medinice, Huons Co, Deltex Medical Group, Neuronetics and Ascom.

Most AOTI public comparables operate across Medical Devices, DeepTech and HealthTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Pro-Dex3.1x2.6x14.6x14.3x
Onward Medical30.5x11.4x(3.0x)(2.4x)
Edap TMS3.1x3.6x(8.8x)(8.1x)
Ilex Medical0.4x-3.4x-
Lucid Diagnostics37.7x30.7x(3.1x)(3.5x)
Medinice-6.7x(117.3x)7.8x
Huons Co0.6x-4.9x-
Deltex Medical Group----

This data is available for Pro users. Sign up to see all AOTI competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About AOTI

When was AOTI founded?AOTI was founded in 2008.
Where is AOTI headquartered?AOTI is headquartered in United States.
Who is the CEO of AOTI?AOTI's CEO is Michael Stephen Griffiths.
Is AOTI publicly listed?Yes, AOTI is a public company listed on London Stock Exchange.
What is the stock symbol of AOTI?AOTI trades under AOTI ticker.
When did AOTI go public?AOTI went public in 2024.
Who are competitors of AOTI?AOTI main competitors include Pro-Dex, Onward Medical, Edap TMS, Ilex Medical, Lucid Diagnostics, Medinice, Huons Co, Deltex Medical Group, Neuronetics, Ascom.
What is the current market cap of AOTI?AOTI's current market cap is $194M.
What is the current revenue of AOTI?AOTI's last 12 months revenue is $71M.
What is the current revenue growth of AOTI?AOTI revenue growth (NTM/LTM) is 15%.
What is the current EV/Revenue multiple of AOTI?Current revenue multiple of AOTI is 2.9x.
What is the current EBITDA of AOTI?AOTI's last 12 months EBITDA is $7M.
What is AOTI's EBITDA margin?AOTI's last 12 months EBITDA margin is 10%.
What is the current EV/EBITDA multiple of AOTI?Current EBITDA multiple of AOTI is 28.7x.
What is the current FCF of AOTI?AOTI's last 12 months FCF is ($3K).
What is AOTI's FCF margin?AOTI's last 12 months FCF margin is (0%).
What is the current EV/FCF multiple of AOTI?Current FCF multiple of AOTI is (57787.2x).
How many companies AOTI has acquired to date?AOTI hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies AOTI has invested to date?AOTI hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to AOTI

Lists including AOTI

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial